Close this search box.

Company Name: Apellis Pharmaceuticals, Inc.

Apellis Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. The company is engaged in development of treatments that are designed to work by inhibiting the complement system in order to treat complement-dependent diseases such as autoimmune and inflammatory diseases.

Ticker Symbol: APLS (NASDAQ)

Company Website:

Social Media:

Apellis Pharmaceuticals Linkedin

Headquarters: Crestwood, Kentucky